| SEQ_NO | 4 | Date of announcement | 2025/05/23 | Time of announcement | 15:36:53 |
| Subject | Announcement of the Election Results for Directors and Supervisor of Major Subsidiary PMC at the 2025 Annual Shareholders' Meeting. | ||||
| Date of events | 2025/05/23 | To which item it meets | paragraph 6 | ||
| Statement | 1.Date of occurrence of the change:2025/05/23 2.Elected or changed position (Please enter institutional director, institutional supervisor, independent director, natural-person director or natural-person supervisor): institutional director, natural-person supervisor 3.Title and name of the previous position holder: (1) Legal Representative of Medeon Biodesign, Inc. Yue Teh Jang; Chairman (2) Legal Representative of Medeon Biodesign, Inc. Albert Weng; Director (3) Legal Representative of Medeon Biodesign, Inc. Jenny Chen; Director (4) Supervisor: Elisa Huang 4.Resume of the previous position holder: (1) Yue Teh Jang; Chairman of PMC (2) Albert Weng; Director of PMC (3) Jenny Chen; Director of PMC (4) Supervisor: Elisa Huang; Supervisor of PMC 5.Title and name of the new position holder: (1) Legal Representative of Medeon Biodesign, Inc. Yue Teh Jang; Chairman (2) Legal Representative of Medeon Biodesign, Inc. Albert Weng; Director (3) Legal Representative of Medeon Biodesign, Inc. Jenny Chen; Director (4) Supervisor: Elisa Huang 6.Resume of the new position holder: (1) Yue Teh Jang; Chairman of PMC (2) Albert Weng; Director of PMC (3) Jenny Chen; Director of PMC (4) Supervisor: Elisa Huang; Supervisor of PMC 7.Circumstances of change (Please enter ‘resignation’, ‘dismissal’, ‘term expired’, ‘death’ or ‘new appointment’):term expired 8.Reason for the change:Term expired re-elected 9.Number of shares held by the new position holder when elected: (1) Legal Representative of Medeon Biodesign, Inc. Yue Teh Jang; 28,761,000 shares (2) Legal Representative of Medeon Biodesign, Inc. Albert Weng; 28,761,000 shares (3) Legal Representative of Medeon Biodesign, Inc. Jenny Chen; 28,761,000 shares (4) Supervisor: Elisa Huang; 0 shares 10.Original term (from __________ to __________):2022/05/27~2025/05/26 11.Effective date of the new appointment:2025/05/23 12.Turnover rate of directors of the same term:NA 13.Turnover rate of independent directors of the same term:NA 14.Turnover rate of supervisors of the same term:NA 15.Change in one-third or more of directors (Please enter ‘Yes’ or ‘No’):No 16.Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 6 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):None |
||||